Wolverine Trading, LLC X4 Pharmaceuticals, Inc Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$0.72 - $1.46 $576 - $1,168	-800 Reduced 5.97%	12,600 $17,000
Q4 2023 Feb 14, 2024	BUY	$0.61 - $0.99 $1,769 - $2,871	2,900 Added 27.62%	13,400 $11,000
Q3 2023 Nov 15, 2023	BUY	$1.03 - $2.02 $10,815 - $21,210	10,500 New	10,500 $11,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.91 $25,960 - $56,345	-29,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.48 - $2.58 $16,132 - $28,122	10,900 Added 58.6%	29,500 $56,000
Q4 2021 Feb 14, 2022	BUY	$1.9 - $5.6 $35,340 - $104,160	18,600 New	18,600 $42,000

105

100M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.